These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8302861)

  • 1. Molecular model of the specificity pocket of the hepatitis C virus protease: implications for substrate recognition.
    Pizzi E; Tramontano A; Tomei L; La Monica N; Failla C; Sardana M; Wood T; De Francesco R
    Proc Natl Acad Sci U S A; 1994 Feb; 91(3):888-92. PubMed ID: 8302861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redesigning the substrate specificity of the hepatitis C virus NS3 protease.
    Failla CM; Pizzi E; De Francesco R; Tramontano A
    Fold Des; 1996; 1(1):35-42. PubMed ID: 9079362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A zinc binding site in viral serine proteinases.
    De Francesco R; Urbani A; Nardi MC; Tomei L; Steinkühler C; Tramontano A
    Biochemistry; 1996 Oct; 35(41):13282-7. PubMed ID: 8873593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Product inhibition of the hepatitis C virus NS3 protease.
    Steinkühler C; Biasiol G; Brunetti M; Urbani A; Koch U; Cortese R; Pessi A; De Francesco R
    Biochemistry; 1998 Jun; 37(25):8899-905. PubMed ID: 9636031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duodenase, a new serine protease of unusual specificity from bovine duodenal mucosa. Primary structure of the enzyme.
    Zamolodchikova TS; Vorotyntseva TI; Nazimov IV; Grishina GA
    Eur J Biochem; 1995 Feb; 227(3):873-9. PubMed ID: 7867649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide-based inhibitors of the hepatitis C virus serine protease.
    Llinàs-Brunet M; Bailey M; Fazal G; Goulet S; Halmos T; Laplante S; Maurice R; Poirier M; Poupart MA; Thibeault D; Wernic D; Lamarre D
    Bioorg Med Chem Lett; 1998 Jul; 8(13):1713-8. PubMed ID: 9873421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitor binding induces active site stabilization of the HCV NS3 protein serine protease domain.
    Barbato G; Cicero DO; Cordier F; Narjes F; Gerlach B; Sambucini S; Grzesiek S; Matassa VG; De Francesco R; Bazzo R
    EMBO J; 2000 Mar; 19(6):1195-206. PubMed ID: 10716920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative analysis of the substrate permissiveness of HCV and GBV-B NS3/4A proteases reveals genetic evidence for an interaction with NS4B protein during genome replication.
    Benureau Y; Warter L; Malcolm BA; Martin A
    Virology; 2010 Oct; 406(2):228-40. PubMed ID: 20701941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-based design of inhibitors of NS3 serine protease of hepatitis C virus.
    Frecer V; Kabelác M; De Nardi P; Pricl S; Miertus S
    J Mol Graph Model; 2004 Jan; 22(3):209-20. PubMed ID: 14629979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substrate specificity of the NS3 serine proteinase of hepatitis C virus as determined by mutagenesis at the NS3/NS4A junction.
    Leinbach SS; Bhat RA; Xia SM; Hum WT; Stauffer B; Davis AR; Hung PP; Mizutani S
    Virology; 1994 Oct; 204(1):163-9. PubMed ID: 8091650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The solution structure of the N-terminal proteinase domain of the hepatitis C virus (HCV) NS3 protein provides new insights into its activation and catalytic mechanism.
    Barbato G; Cicero DO; Nardi MC; Steinkühler C; Cortese R; De Francesco R; Bazzo R
    J Mol Biol; 1999 Jun; 289(2):371-84. PubMed ID: 10366511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel substrate-binding pocket interaction restricts the specificity of the human NK cell-specific serine protease, Met-ase-1.
    Smyth MJ; O'Connor MD; Trapani JA; Kershaw MH; Brinkworth RI
    J Immunol; 1996 Jun; 156(11):4174-81. PubMed ID: 8666785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homology modeling and molecular dynamics simulations of Dengue virus NS2B/NS3 protease: insight into molecular interaction.
    Wichapong K; Pianwanit S; Sippl W; Kokpol S
    J Mol Recognit; 2010; 23(3):283-300. PubMed ID: 19693793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The crystal structure of the Epstein-Barr virus protease shows rearrangement of the processed C terminus.
    Buisson M; Hernandez JF; Lascoux D; Schoehn G; Forest E; Arlaud G; Seigneurin JM; Ruigrok RW; Burmeister WP
    J Mol Biol; 2002 Nov; 324(1):89-103. PubMed ID: 12421561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hepatitis C virus NS3 proteinase: structure and function of a zinc-containing serine proteinase.
    De Francesco R; Pessi A; Steinkühler C
    Antivir Ther; 1998; 3(Suppl 3):99-109. PubMed ID: 10726060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic role of an NS4A peptide cofactor with the truncated NS3 protease of hepatitis C virus: elucidation of the NS4A stimulatory effect via kinetic analysis and inhibitor mapping.
    Landro JA; Raybuck SA; Luong YP; O'Malley ET; Harbeson SL; Morgenstern KA; Rao G; Livingston DJ
    Biochemistry; 1997 Aug; 36(31):9340-8. PubMed ID: 9235976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative molecular model building of two serine proteinases from cytotoxic T lymphocytes.
    Murphy ME; Moult J; Bleackley RC; Gershenfeld H; Weissman IL; James MN
    Proteins; 1988; 4(3):190-204. PubMed ID: 3237717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural characterization of the interactions of optimized product inhibitors with the N-terminal proteinase domain of the hepatitis C virus (HCV) NS3 protein by NMR and modelling studies.
    Cicero DO; Barbato G; Koch U; Ingallinella P; Bianchi E; Nardi MC; Steinkühler C; Cortese R; Matassa V; De Francesco R; Pessi A; Bazzo R
    J Mol Biol; 1999 Jun; 289(2):385-96. PubMed ID: 10366512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the protease domain in NS3 of hepatitis C virus.
    Han DS; Hahm B; Rho HM; Jang SK
    J Gen Virol; 1995 Apr; 76 ( Pt 4)():985-93. PubMed ID: 9049347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of hepatitis C virus NS3 protease and helicase activities through the interaction with NS4A.
    Gallinari P; Paolini C; Brennan D; Nardi C; Steinkühler C; De Francesco R
    Biochemistry; 1999 Apr; 38(17):5620-32. PubMed ID: 10220351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.